Video Experimental Relacionado
Updated: Jul 6, 2026
10:41
The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
Una vía convergente enantioselectiva hacia los antibióticos 6-deoxitetraciclina estructuralmente diversos
Mark G Charest1, Christian D Lerner, Jason D Brubaker
1Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Science (New York, N.Y.)
|April 16, 2005
Resumen
Los investigadores desarrollaron una nueva ruta sintética para diversos antibióticos de 6-deoxitetraciclina, expandiendo el potencial de los candidatos a antibióticos. Este método permite variaciones estructurales, particularmente en el anillo D, superando las limitaciones de la semisíntesis tradicional.
Área de la Ciencia:
- Química orgánica es la química orgánica.
- Química Medicinal La Química Medicinal es el campo de la Química Medicinal.
- Biología sintética Biología sintética.
Sus antecedentes:
- Los antibióticos complejos generalmente se derivan de productos naturales a través de la semisíntesis.
- La semisíntesis limita la diversidad estructural y la exploración de nuevos candidatos a antibióticos.
- El desarrollo de nuevas rutas sintéticas es crucial para expandir la tubería de descubrimiento de fármacos antibióticos.
Objetivo del estudio:
- Establecer una ruta sintética corta y enantioselectiva para una amplia gama de antibióticos de 6-deoxitetraciclina.
- Para permitir la variabilidad estructural, centrándose en el anillo D, para el desarrollo de nuevos antibióticos.
- Para superar las limitaciones de la semisíntesis en el acceso a nuevas estructuras de antibióticos.
Principales métodos:
- Desarrolló una estrategia de construcción de anillos C diastereoselectivos en etapa tardía.
- Acoplado estructuralmente variados precursores de anillo D con un precursor AB.
- Utilizado ácido benzoico como material de partida para la síntesis.
Principales resultados:
- Se han sintetizado con éxito cinco derivados de los antibióticos 6-deoxitetraciclina con rendimientos entre el 5-7% en 14-15 pasos.
- La (-) -doxiciclina sintetizada en un 8,3% da rendimiento en 18 pasos.
- Demostró un enfoque sintético versátil para crear diversas estructuras de antibióticos.
Conclusiones:
- La ruta sintética desarrollada proporciona acceso a una amplia gama de estructuras de 6-deoxitetraciclina.
- Este enfoque amplía significativamente el alcance de los posibles candidatos a antibióticos más allá de las limitaciones de los productos naturales.
- La metodología facilita el estudio de las relaciones estructura-actividad para el desarrollo de antibióticos.
Videos de Conceptos Relacionados
00:57Antibiotic Selection
Overview
01:30The Electron Transport Chain
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...